Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on May 9, 2025
New Five-Year Agreement with the Alberta Sugar Beet Growers
GlobeNewswire
·
May 9, 2025
MONTRÉAL and VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- Rogers Sugar Inc. (the “Corporation” or “Rogers Sugar”) (TSX: RSI) is pleased to announce a five-year agreement with the Alberta Sugar Beet Growers (“ASBG”) for the supply of sugar …
Nouvel accord de cinq ans avec Les producteurs de betteraves à sucre de l’Alberta
GlobeNewswire
·
May 9, 2025
MONTRÉAL et VANCOUVER, Colombie-Britannique, 09 mai 2025 (GLOBE NEWSWIRE) -- Rogers Sugar inc. (la « Société » ou « Rogers Sugar ») (TSX : RSI) est heureuse d’annoncer la conclusion d’un accord de cinq ans avec Les producteurs de betteraves à sucre de l’ …
Tree Island Steel Announces First Quarter 2025 Results
GlobeNewswire
·
May 9, 2025
VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- Tree Island Steel (''Tree Island'' or the ''Company'') (TSX: TSL) announced today its financial results for the three months ended March 31, 2025. For the three-month period ended March 31, 2025 …
Labrador Gold Announces Resignation of Director Kai Hoffmann
GlobeNewswire
·
May 9, 2025
TORONTO, May 09, 2025 (GLOBE NEWSWIRE) -- Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) announces the resignation of Kai Hoffmann as a director of the Company. Mr. Hoffmann has been an integral part of the Board of …
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, today announced that it will present full 12 …
Orezone Gold Reports Fatality at Stage I Hard Rock Plant Construction Site
GlobeNewswire
·
May 9, 2025
VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) regrets to report a fatality at the Stage I hard rock plant construction site at its Bomboré Gold Mine which occurred on Thursday …
Annexon Announces Presentations on the Clinical Advancement of Tanruprubart as the First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) at the 2025 PNS Meeting
GlobeNewswire
·
May 9, 2025
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compared to Current Standards of Care in Matched Patient …
HealthEquity Announces First Quarter Earnings Release Date Presentations at Investor Conferences
GlobeNewswire
·
May 9, 2025
DRAPER, Utah, May 09, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest health savings account (“HSA") custodian, today announced plans to release its first quarter of fiscal 2026 financial …
Theriva Biologics anuncia el cierre de una oferta pública de 7,5 millones de dólares
GlobeNewswire
·
May 9, 2025
ROCKVILLE, Maryland, May 09, 2025 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), («Theriva» o la «empresa»), una empresa diversificada en fase clínica que desarrolla terapias diseñadas para tratar el cáncer y enfermedades relacionadas en …
Source Energy Services Reports 2025 AGM Results
GlobeNewswire
·
May 9, 2025
CALGARY, Alberta, May 09, 2025 (GLOBE NEWSWIRE) -- – (TSX:SHLE) Source Energy Services Ltd. (“Source” or the “Company”) reports results from its annual meeting shareholder held May 9, 2025. 2025 AGM Voting Results Election of Directors All of the proposed …
Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases
GlobeNewswire
·
May 9, 2025
New breakthrough data from studies with Coave’s ALIGATER™-engineered AAV2-based capsid coAAV-CSF-01 (S01coAAV2) demonstrates improved brain tissue transduction and safety following intra-cerebrospinal fluid administration in non-human primates Data …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
CAMBRIDGE, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Vital Battery Metals Announces Effective Date of Name Change to Aventis Energy Inc.
GlobeNewswire
·
May 9, 2025
VANCOUVER, British Columbia, May 09, 2025 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), announces that effective Tuesday, May 13, 2025, the Company’s name will change to “Aventis Energy Inc.”. …
Watch The European's interview with Gary Yohe on Extreme Weather and Adaptive Strategies
EIN Presswire
·
May 9, 2025
LONDON, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- Extreme weather events - such as heatwaves and flash floods – are inflicting a high cost on humanity, the environment, and financial structures. As the authorities in the United States recently …
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
GlobeNewswire
·
May 9, 2025
SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and …
Twin Disc Approves a Quarterly Cash Dividend
GlobeNewswire
·
May 9, 2025
MILWAUKEE, May 09, 2025 (GLOBE NEWSWIRE) -- Twin Disc, Inc. (NASDAQ: TWIN), today announced that the Board of Directors (the "Board") approved a regular quarterly cash dividend of $0.04 per share payable on June 2, 2025, to shareholders of record at the …
Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 9, 2025
SOUTH SAN FRANCISCO, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and regeneration …
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee …
PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 9, 2025
PRINCETON, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …